Table 3.

Distribution (%) of abnormal cervical cancer screening results among women receiving their first Pap test in the National Breast and Cervical Cancer Early Detection Program, by screening history, 2002–2012

Totala	Screening history		Difference (NR–P5Y %)
	NR	P5Y
	Total abnormal Pap testsb (%)
	2.9	2.6	0.3*
Age group (years)
18–20	8.8	15.3	−6.5*
21–29	8.0	10.8	−2.8*
30–39	4.6	4.6	−0.1
40–49	3.1	2.6	0.5*
50–59	2.3	1.8	0.5*
60–64	1.9	1.4	0.5*
≥65	2.1	1.5	0.6*
Race/ethnicitya
White	3.3	3.1	0.3
African-American	2.6	2.5	0.1
Asian/Pacific Islander	2.1	1.8	0.3
American Indian/Alaska Native	2.0	2.0	<0.1
Multiracial/unknown	2.4	2.3	0.1
Hispanic	2.6	2.1	0.5*
Rural–urbana
Metro	2.8	2.5	0.3*
Urban	3.1	2.9	0.2
Rural	3.1	2.7	0.3
Unknown	2.0	1.3	0.7*
Regiona
Territory	1.9	1.6	0.4
Northeast	2.7	2.5	0.3*
Midwest	3.5	3.3	0.2*
South	3.1	2.8	0.3*
West	2.4	2.0	0.4*

NR never or rarely (not screened within 5 years) screened, P5Y screened within last 5 years

^*p values significantly different at <0.05 from separate nested logistic models of abnormal Pap test with age, race/ethnicity, rural–urban, or region associated with screening history

^aPercentages age-adjusted to the 2000 National Breast and Cervical Cancer Early Detection Program

^bIncludes the following Pap test results: atypical glandular cells, atypical squamous cells of undetermined significance—cannot exclude high-grade squamous intraepithelial lesion, high-grade squamous intraepithelial lesion, and squamous cell carcinoma